Hormones corticosurrénaliennes < Humains < Hydroxychloroquine

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f Mesh.f MeshFr.f Teeft.f

List of bibliographic references

Number of relevant bibliographic references: 35.
[20-40] [0 - 20][0 - 35]

Ident.	Authors (with country if any)	Title
000494 (2020)	Naoto Sakumura [Japon] ; Hitoshi Irabu [Japon] ; Natsumi Inoue [Japon] ; Mao Mizuta [Japon] ; Masaki Shimizu [Japon]	Clinical usefulness of longitudinal IL-6 monitoring in a patient with Takayasu aortitis receiving tocilizumab.
000521 (2020)	Jon T. Giles [États-Unis] ; Naveed Sattar [Royaume-Uni] ; Sherine Gabriel [États-Unis] ; Paul M. Ridker [États-Unis] ; Steffen Gay [Suisse] ; Charles Warne [Royaume-Uni] ; David Musselman [États-Unis] ; Laura Brockwell [Royaume-Uni] ; Emma Shittu [Royaume-Uni] ; Micki Klearman [États-Unis] ; Thomas R. Fleming [États-Unis]	Cardiovascular Safety of Tocilizumab Versus Etanercept in Rheumatoid Arthritis: A Randomized Controlled Trial.
000544 (2020)	Carina Mihai [Suisse] ; Rucsandra Dobrota [Suisse] ; Maria Schröder [Suisse] ; Alexandru Garaiman [Suisse] ; Suzana Jordan [Suisse] ; Mike Oliver Becker [Suisse] ; Britta Maurer [Suisse] ; Oliver Distler [Suisse]	COVID-19 in a patient with systemic sclerosis treated with tocilizumab for SSc-ILD.
000571 (2020)	Seong-Kyu Kim ; Sang Gyu Kwak [Corée du Sud] ; Jung-Yoon Choe	Association between biologic disease modifying anti-rheumatic drugs and incident hypertension in patients with rheumatoid arthritis: Results from prospective nationwide KOBIO Registry.
000582 (2020)	Franco Maria Buonaguro [Italie] ; Igor Puzanov [États-Unis] ; Paolo Antonio Ascierto [Italie]	Anti-IL6R role in treatment of COVID-19-related ARDS
000586 (2020)	Tomohiro Koga ; Naoko Hagimori [Japon] ; Shuntaro Sato [Japon] ; Shinpei Morimoto [Japon] ; Naoki Hosogaya [Japon] ; Chizu Fukushima [Japon] ; Hiroshi Yamamoto [Japon] ; Atsushi Kawakami	An open-label continuation trial of tocilizumab for familial Mediterranean fever with colchicine ineffective or intolerance
000587 (2020)	A. Ahmad [Arabie saoudite] ; M U Rehman ; K M Alkharfy	An alternative approach to minimize the risk of coronavirus (Covid-19) and similar infections.
000613 (2020)	Bernhard Hellmich [Allemagne] ; Ana Agueda [Portugal] ; Sara Monti [Italie] ; Frank Buttgereit [Allemagne] ; Hubert De Boysson [France] ; Elisabeth Brouwer [Pays-Bas] ; Rebecca Cassie [Royaume-Uni] ; Maria C. Cid [Espagne] ; Bhaskar Dasgupta [Royaume-Uni] ; Christian Dejaco [Autriche] ; Gulen Hatemi [Turquie] ; Nicole Hollinger [Allemagne] ; Alfred Mahr [France] ; Susan P. Mollan [Royaume-Uni] ; Chetan Mukhtyar [Royaume-Uni] ; Cristina Ponte [Portugal] ; Carlo Salvarani [Italie] ; Rajappa Sivakumar [Inde] ; Xinping Tian [République populaire de Chine] ; Gunnar Tomasson [Islande] ; Carl Turesson [Suède] ; Wolfgang Schmidt [Allemagne] ; Peter M. Villiger [Suisse] ; Richard Watts [Royaume-Uni] ; Chris Young [Royaume-Uni] ; Raashid Ahmed Luqmani [Royaume-Uni]	2018 Update of the EULAR recommendations for the management of large vessel vasculitis.
000614 (2020)	Haneul Kim [Corée du Sud] ; Seungye Baek [Corée du Sud] ; Seung-Min Hong [Corée du Sud] ; Jaeseon Lee [Corée du Sud] ; Seung Min Jung [Corée du Sud] ; Jennifer Lee [Corée du Sud] ; Mi-La Cho [Corée du Sud] ; Seung-Ki Kwok [Corée du Sud] ; Sung-Hwan Park [Corée du Sud]	1,25-dihydroxy Vitamin D3 and Interleukin-6 Blockade Synergistically Regulate Rheumatoid Arthritis by Suppressing Interleukin-17 Production and Osteoclastogenesis
000623 (2016)	Nozomu Yanaihara [Japon] ; Yukihiro Hirata [Japon] ; Noriko Yamaguchi [Japon] ; Yukiko Noguchi [Japon] ; Misato Saito [Japon] ; Chie Nagata [Japon] ; Satoshi Takakura [Japon] ; Kyosuke Yamada [Japon] ; Aikou Okamoto [Japon]	Antitumor effects of interleukin‐6 (IL‐6)/interleukin‐6 receptor (IL‐6R) signaling pathway inhibition in clear cell carcinoma of the ovary
000624 (2015)	Raja Atreya [Allemagne] ; Ulrike Billmeier [Allemagne] ; Timo Rath [Allemagne] ; Jonas Mudter [Allemagne] ; Michael Vieth [Allemagne] ; Helmut Neumann [Allemagne] ; Markus F. Neurath [Allemagne]	First case report of exacerbated ulcerative colitis after anti-interleukin-6R salvage therapy.
000625 (2013)	Katsutoshi Ando [Japon] ; Fumiyuki Takahashi ; Shinji Motojima ; Kei Nakashima ; Norihiro Kaneko ; Kazuei Hoshi ; Kazuhisa Takahashi	Possible role for tocilizumab, an anti-interleukin-6 receptor antibody, in treating cancer cachexia.
000630 (2009)	Miho Suzuki [Japon] ; Misato Hashizume [Japon] ; Hiroto Yoshida [Japon] ; Masahiko Mihara [Japon]	Anti-inflammatory mechanism of tocilizumab, a humanized anti-IL-6R antibody: effect on the expression of chemokine and adhesion molecule
000632 (????)	-. Lombardy Section Italian Society Infectious And Tropical Diseases	Vademecum for the treatment of people with COVID-19. Edition 2.0, 13 March 2020.
000636 (????)	Melissa Bersanelli [Italie]	Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/2020/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/MeshFr.i -k "Humains" 

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/MeshFr.i  \
                -Sk "Humains" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    2020
   |étape=   Analysis
   |type=    indexItem
   |index=    MeshFr.i
   |clé=    Humains
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021